On Friday, Shares of Oracle Corporation (NYSE:ORCL), climbed 0.30% to $ 40.36.
Oracle Corporation, unveiled Oracle Commerce Cloud, a flexible and scalable SaaS solution built for the Oracle Public Cloud. Oracle Commerce Cloud features the latest commerce technology and is designed to ignite business innovation and rapid growth, while simplifying IT administration and reducing costs.
Oracle Commerce Cloud’s modern SaaS infrastructure emphasizes simplicity, allowing online businesses to quickly launch feature-rich, responsive storefronts across desktop and mobile devices without sacrificing features or brand control. No longer limited by cookie-cutter site options, marketers and merchants get a fully responsive, configurable storefront out-of-the-box with pre-integrated core commerce features counting: search / navigation, recommendations, promotions, reporting, payments, design templates and SEO. Catalog, content, design and merchandising administration is all at the business’ fingertips in a unified experience administration console.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
Shares of EnteroMedics Inc (NASDAQ:ETRM), dipped -11.11% to $0.529.
EnteroMedics Inc, declared the pricing of its formerly declared public offering of 40,229,886 units. Each unit comprises of one share of common stock, 0.50 of a Series A warrant to purchase one share of common stock, and 0.50 of a Series B warrant to purchase one share of common stock, at a purchase price of $0.87 per unit. Investors whose purchase of units in the offering would result in them beneficially owning more than the initial beneficial ownership limitation to be comprised of in the warrants following the consummation of the offering will have the opportunity to acquire units with Series C pre-funded warrants substituted for any common stock they would have otherwise attained over the initial beneficial ownership limitation, paying the same price of $0.87 per unit. The Series A warrants will be exercisable right away and will expire three years following issuance at an exercise price of $1.00 per share. The Series B warrants will be exercisable right away and will expire 12 months following issuance at an exercise price of $1.09 per share. The pre-funded Series C warrants will be exercisable right away and will expire five years following issuance.
Canaccord Genuity is acting as sole book-running manager and Craig-Hallum Capital Group is acting as co-manager for the offering. Northland Securities and Roth Capital Partners served as financial advisors to the Company in connection with this transaction.
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
Finally, Axalta Coating Systems Ltd (NYSE:AXTA), lost -0.43% $32.50.
Axalta Coating Systems, a leading global supplier of liquid and powder coatings, accomplished the acquisition of Metalak Benelux B.V. For more than 60 years, Metalak has been the exclusive distributor of Axalta’s Spies Hecker refinish coating products sold in the Netherlands and in Flanders, Belgium. Formerly a privately owned company, Metalak has offices in Bornem, Belgium and in Tiel, the Netherlands and will continue to operate under the Metalak name. The agreement will take effect right away.
Dirk Lippens, Country Business Manager for Axalta in the Benelux, says, “Metalak has been operating successfully in the premium segment of the refinish market in the Netherlands and in Belgium for many years, and has established long-term relationships with hundreds of independent body shops and several repair networks. This acquisition strengthens Axalta’s position in the market and is designed to optimise our operational infrastructure while at the same time complement our sales activities. We have a fantastic opportunity to grow our business in these two fast-paced European markets. The entire Benelux team is completely focused on our customers and we look forward to the new opportunities this acquisition brings with it.
Axalta Coating Systems Ltd., through its auxiliaries, manufactures, markets, and distributes high performance coatings products primarily for the transportation industry. It operates through two segments, Performance Coatings and Transportation Coatings.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
